Attralus is a California-based biopharmaceutical company that develops novel pan-amyloid removal therapeutics for the treatment of systemic amyloid diseases.
Business Model:
Revenue: $2M
Employees: 11-50
Address: 329 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Attralus is a California-based biopharmaceutical company that develops novel pan-amyloid removal therapeutics for the treatment of systemic amyloid diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Series A | 1 | $25M |
venBio Partners venBio Partners |
9/2021 | Series B | 8 | $116M |
Janus Henderson Investors Logos Capital Redmile Group Samsara BioCapital Sarissa Capital Management Surveyor Capital venBio Partners Vivo Capital Janus Henderson Investors Logos Capital Redmile Group Samsara BioCapital Sarissa Capital Management Surveyor Capital venBio Partners Vivo Capital |
10/2019 | Seed | - | 10/2019 | Seed | - |
VenBio Partners VenBio Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|